Biocept
BIOC
$0.43
Share price
0.00%
Change (1 day)
-95.74%
Change (1 year)
Categories
P/S ratio for Biocept (BIOC)
P/S ratio as of May 2024 (TTM): -0.3324
According to Biocept 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is -0.332381. At the end of 2023 the company had a P/S ratio of N/A.
P/S ratio history for Biocept from 2014 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | N/A | -100% |
| 2022 | 0.3496 | -64.87% |
| 2021 | 0.9954 | -54.04% |
| 2020 | 2.17 | -23.51% |
| 2019 | 2.83 | 131.16% |
| 2018 | 1.22 | -74.57% |
| 2017 | 4.82 | 14.47% |
| 2016 | 4.21 | -90.55% |
| 2015 | 44.5 | -46.19% |
| 2014 | 82.7 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 Veracyte VCYT | 4.27 | -1,386.16% | 🇺🇸 USA |
 Exact Sciences EXAS | 4.45 | -1,439.59% | 🇺🇸 USA |
 Myriad Genetics MYGN | 2.31 | -794.63% | 🇺🇸 USA |